At Theragent Inc, we constantly are researching and testing new methods to help deliver the therapeutics of tomorrow to patients in need of them today. Download our latest white paper to see how we are driving new methods to generate NK cells using a feeder-free platform with reduced risks. #NKcells #CGT #CDMO #whitepaper
Feeder-free Natural Killer (NK) cell expansion systems are a desirable choice for clinical applications due to reduced safety risks. However, historically lower expansion rates of these systems present a challenge to widespread clinical adoption and are a key reason why feeder-based expansion systems are still frequently used, despite safety and regulatory risks. Check out Theragent's latest research, led by Raymond Wu Ph.D., on an innovative NK cell therapy solution that can help overcome this barrier. https://lnkd.in/gYQj2mDJ #CAGT #NKCELL #THERAGENT